Higher fibrinogen and neutrophil-to-lymphocyte ratio are associated with the early poor response to intravenous thrombolysis in acute ischemic stroke
Open Access
- 22 February 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1291950
Abstract
Background: Inflammation and platelet activation play pivotal roles in acute ischemic stroke (AIS) pathogenesis. Early response to thrombolysis is a vital indicator for the long-term prognosis of AIS. However, the correlation between fibrinogen or the neutrophil-to-lymphocyte ratio (NLR) and the early response to intravenous thrombolysis in patients with AIS remains unclear.Methods: AIS patients undergoing intravenous thrombolysis were enrolled between January 2018 and May 2023. Blood cell counts were sampled before thrombolysis. A good response was defined as a National Institutes of Health Stroke Scale (NIHSS) score decreased ≥4 or complete recovery 24 h after thrombolysis treatment. A poor response was defined as any increase in the NIHSS score or a decrease in the NIHSS score P < 0.001) and NLR (OR, 1.253; 95% CI, 1.210–2.005, P = 0.001) were independent factors for a poor response. The area under the curve (AUC) values for the fibrinogen level, NLR and fibrinogen level combined with the NLR for a poor response were 0.708, 0.605, and 0.728, respectively.Conclusions: Our research indicates that the levels of fibrinogen and NLR at admission can be used as a prognostic factor to predict early poor response to intravenous thrombolysis.Keywords
This publication has 60 references indexed in Scilit:
- Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic StrokeJAMA Neurology, 2023
- Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry ⅢAtherosclerosis, 2021
- Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's DiseaseMovement Disorders, 2021
- Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-AnalysisTranslational Stroke Research, 2021
- Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic StrokeCellular and Molecular Neurobiology, 2020
- Neutrophil–lymphocyte ratio predicts post‐thrombolysis early neurological deterioration in acute ischemic stroke patientsBrain and Behavior, 2019
- Management of Acute Ischemic StrokeThe American Journal of Medicine, 2019
- Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen ActivatorJAMA Neurology, 2014
- Fibrinogen as a key regulator of inflammation in diseaseSeminars in Immunopathology, 2011
- Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular MortalityJAMA, 2005